Clinical study of modified Banxia Xiexin Decoction on improving urinary microalbuminuria in patients with diabetic nephropathy by regulating intestinal function

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035729

Enrollment

Unknown

Registered

2020-08-16

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

1:Banxia Xiexin Decoction

2:westernmedicine

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: western medicine diagnostic criteria: according to Ada (2014) diagnostic criteria, diabetic nephropathy was definitely diagnosed as diabetes, GFR < 60ml / min / 1.73m2 or urinary albumin / creatinine ratio (ACR) was higher than 30mg / g for more than 3 months;

Exclusion criteria

Exclusion criteria: Uncooperative; patients with serious heart, liver, kidney, brain and other complications, or combined with other serious consumptive diseases, mental diseases; combined with other diseases affecting glucose and lipid metabolism, such as hyperthyroidism; patients with diabetic ketosis, ketoacidosis and infection in recent 1 month; patients with renal dysfunction caused by other reasons.

Design outcomes

Primary

Measure	Time frame
urinary protein;	—

Countries

China

Contacts

Public ContactZhang Hongyan

Shanghai Sixth People's Hospital

zhhyzl@163.com+86 18930172984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026